Insider Selling: Hinge Health (NYSE:HNGE) President Sells 15,000 Shares of Stock

Hinge Health Inc. (NYSE:HNGE) President James Pursley sold 15,000 shares of the stock in a transaction that occurred on Friday, November 21st. The shares were sold at an average price of $45.57, for a total transaction of $683,550.00. Following the sale, the president owned 789,902 shares in the company, valued at approximately $35,995,834.14. The trade was a 1.86% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Hinge Health Stock Up 2.3%

NYSE HNGE traded up $1.08 during mid-day trading on Monday, reaching $47.07. The stock had a trading volume of 1,715,754 shares, compared to its average volume of 1,186,414. Hinge Health Inc. has a 1 year low of $33.42 and a 1 year high of $62.18. The business’s fifty day moving average price is $49.69.

Hinge Health (NYSE:HNGE) last released its quarterly earnings data on Tuesday, November 4th. The company reported ($0.02) EPS for the quarter, beating the consensus estimate of ($0.20) by $0.18. The business had revenue of $154.21 million for the quarter, compared to analysts’ expectations of $142.44 million. The firm’s revenue was up 53.3% compared to the same quarter last year. Hinge Health has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS.

Hinge Health declared that its Board of Directors has authorized a share buyback plan on Wednesday, November 12th that authorizes the company to buyback $250.00 million in outstanding shares. This buyback authorization authorizes the company to buy up to 7.2% of its stock through open market purchases. Stock buyback plans are usually an indication that the company’s leadership believes its shares are undervalued.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on HNGE shares. Stifel Nicolaus lifted their target price on shares of Hinge Health from $63.00 to $66.00 and gave the stock a “buy” rating in a research report on Thursday, September 11th. Needham & Company LLC raised their price target on Hinge Health from $47.00 to $59.00 and gave the stock a “buy” rating in a research note on Wednesday, August 6th. Barclays upped their price objective on Hinge Health from $62.00 to $65.00 and gave the company an “overweight” rating in a research report on Wednesday, November 5th. Morgan Stanley raised their target price on Hinge Health from $57.00 to $67.00 and gave the stock an “overweight” rating in a research report on Tuesday, September 23rd. Finally, Bank of America boosted their price target on Hinge Health from $42.00 to $64.00 and gave the company a “buy” rating in a research note on Wednesday, August 6th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $59.93.

Institutional Investors Weigh In On Hinge Health

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Mirae Asset Global Investments Co. Ltd. purchased a new position in Hinge Health during the third quarter valued at $37,000. Montag A & Associates Inc. purchased a new stake in Hinge Health in the second quarter worth about $41,000. SBI Securities Co. Ltd. bought a new position in shares of Hinge Health in the second quarter worth about $48,000. Aster Capital Management DIFC Ltd purchased a new position in shares of Hinge Health during the 3rd quarter valued at about $49,000. Finally, Jones Financial Companies Lllp grew its stake in shares of Hinge Health by 348.0% during the 3rd quarter. Jones Financial Companies Lllp now owns 1,120 shares of the company’s stock valued at $54,000 after acquiring an additional 870 shares during the period.

About Hinge Health

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.